Alx Oncology Holdings Inc filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-06-30. Between them they name 2 people, with 1 appointment and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Departing: Corey Goodman
Dr. Goodman resigned for personal reasons and not as a result of any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.
Appointed: Jeff Knight, Chief Development and Operating Officer, effective 2026-04-13
Effective April 13, 2026, the Board of Directors (the "Board") of ALX Oncology Holdings Inc. (the "Company") appointed Jeff Knight as Chief Development and Operating Officer.
Find people with the same kind of experience as the Chief Development and Operating Officer at Alx Oncology Holdings Inc, with the record behind each one.
Find candidates like Chief Development and Operating Officer at Alx Oncology Holdings IncNew leaders review vendors and budgets in their first months. Get an alert the next time Alx Oncology Holdings Inc is in the news or changes leadership.
Get an alert when Alx Oncology Holdings Inc changes leadershipTools for this story
Each opens in a new tab, filled in for Alx Oncology Holdings Inc. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.